Literature DB >> 29952162

Hepatitis C treatment – yesterday, tomorrow and …

Christof Weitzel.   

Abstract

During the last years, treatment of chronic hepatitis C virus infection (HCV) was characterized by the development of new therapeutic agents and their combined use. By now the problem of treating HCV seems to be largely solved. The broad range of available therapeutics has the potential to enable a complete cure of this liver disease, which is associated with many complications, thus providing also economic benefits.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29952162

Source DB:  PubMed          Journal:  Med Monatsschr Pharm        ISSN: 0342-9601


  1 in total

1.  A descriptive study of racial inequalities in mortality from hepatocellular cancer before and after licensure of lifesaving drugs for hepatitis C virus in the United States.

Authors:  Robert S Levine; Maria C Mejia; Jason L Salemi; Sandra J Gonzalez; Muktar H Aliyu; Baqar A Husaini; Roger J Zoorob; Charles H Hennekens
Journal:  EClinicalMedicine       Date:  2020-04-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.